株探米国株
日本語 英語
エドガーで原本を確認する
false000094414800009441482023-07-272023-07-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
July 27, 2023
Date of Report (Date of earliest event reported)
CBIZ, Inc.
(Exact name of registrant as specified in its charter)
Delaware 1-32961 22-2769024
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
6801 Brecksville Rd., Door N
Independence, Ohio 44131
(Address of principal executive offices, including zip code)
216-447-9000
(Registrant's telephone number, including area code)
Note Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading
Symbol(s)
Name of each exchange
On which registered
Common Stock per value $0.01 per share CBZ New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
☐    Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Item 2.02    Results of Operations and Financial Condition
On July 27, 2023, CBIZ, Inc. (the "Company") issued a press release announcing its financial results for the three and six months ended June 30, 2023. A copy of the press release is furnished herewith as Exhibit 99.1. The exhibit contains, and may implicate, forward-looking statements regarding the Company and include cautionary statements identified important factors that could cause actual results to differ materially from those anticipated.

Item 9.01    Financial Statements and Exhibits
(d)    Exhibits
99.1    Press Release of CBIZ, Inc. dated July 27, 2023, announcing its financial results for the three and six months ended June 30, 2023.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES:
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 27, 2023

CBIZ, Inc.

By: /s/ Ware H. Grove
Name: Ware H. Grove
Title: Chief Financial Officer


EX-99.1 2 q22023earningrelease.htm EX-99.1 Document



Exhibit 99.1

cbiznewlogoa.jpg
     
prpicturea.jpg
FOR IMMEDIATE RELEASE CONTACT:    Ware Grove
      Chief Financial Officer
      -or-
      Lori Novickis
      Director, Corporate Relations
      CBIZ, Inc.
      Cleveland, Ohio
      (216) 447-9000
CBIZ REPORTS SECOND-QUARTER AND FIRST-HALF 2023 RESULTS
AND RAISES FULL-YEAR 2023 REVENUE GUIDANCE
SECOND-QUARTER HIGHLIGHTS:
•TOTAL REVENUE UP 10.1%; SAME-UNIT REVENUE UP 4.1%
•GAAP EPS DOWN 11.7%; ADJUSTED EPS DOWN 12.7%
•NET INCOME DOWN 14.1%; ADJUSTED EBITDA DOWN 2.3%
FIRST-HALF HIGHLIGHTS:
•TOTAL REVENUE UP 13.2%; SAME-UNIT REVENUE UP 7.2%
•GAAP EPS UP 16.5%; ADJUSTED EPS UP 11.0%
•NET INCOME UP 11.9%; ADJUSTED EBITDA UP 12.9%

CLEVELAND (July 27, 2023) – CBIZ, Inc., (NYSE: CBZ) (“CBIZ” or the “Company”), a leading provider of financial, insurance and advisory services, today announced results for the second quarter ended June 30, 2023.
For the 2023 second quarter, CBIZ recorded revenue of $398.5 million, an increase of $36.6 million, or 10.1%, compared with $362.0 million reported for the same period in 2022. Acquired operations, net of divestitures, contributed $21.6 million, or 6.0%, to revenue growth. Same-unit revenue increased by $15.0 million, or 4.1%, for the quarter, compared with the same period a year ago. Net income was $26.9 million, or $0.53 per diluted share, compared with $31.3 million, or $0.60 per diluted share, for the same period a year ago.
For the six months ended June 30, 2023, CBIZ recorded revenue of $853.1 million, an increase of $99.4 million, or 13.2%, over the $753.7 million recorded for the same period in 2022. Acquisitions, net of divestitures, contributed $45.5 million, or 6.0%, to revenue growth in the six months ended June 30, 2023. Same-unit revenue increased by $53.9 million, or 7.2%, compared with the same period a year ago. Net income was $100.0 million, or $1.98 per diluted share, for the six months ended June 30, 2023, compared with $89.4 million, or $1.70 per diluted share, for the same period a year ago.
Page 1 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz




Excluding non-recurring transaction and first-year integration expenses related to the acquisition of Marks Paneth in January 2022, and expenses related to the acquisition of Somerset in February 2023, Adjusted net income was $27.6 million in the second quarter of 2023 compared with Adjusted net income of $32.7 million for the same period a year ago. Adjusted earnings per share was $0.55, a decrease of 12.7% compared with Adjusted earnings per share of $0.63 for the same period a year ago. Adjusted EBITDA for the second quarter was $54.4 million, down 2.3% compared with $55.7 million for the same period in 2022.
Adjusted net income was $102.0 million, or $2.01 per diluted share, for the six months ended June 30, 2023, compared with $95.3 million, or $1.81 per diluted share, for the same period a year ago. Adjusted EBITDA for the six months was $167.8 million, compared with $148.6 million for the same period in 2022.
Schedules reconciling Adjusted net income, Adjusted earnings per share and Adjusted EBITDA to the most directly comparable GAAP measures can be found in the tables included in this release.
During the six months ended June 30, 2023, the Company repurchased approximately 1.0 million shares of its common stock on the open market. The balance outstanding on the Company’s unsecured credit facility on June 30, 2023, was $410.6 million with $177.5 million of unused borrowing capacity.

Jerry Grisko, CBIZ President and Chief Executive Officer, said, “Following an exceptionally strong first quarter, our core businesses continued to perform well during the second quarter, and demand for our financial services, including accounting, tax and our advisory services, as well as our benefits and insurance offerings, remains strong. Our second-quarter results came in much as we expected with the exception of two areas that are largely beyond our control – contract delays in our Government Health Care consulting business and changes to tax filing deadlines in California. Based on our year-to-date performance and current outlook for the remainder of the year, we are pleased to raise revenue guidance and reaffirm our EPS guidance for the full year.”

“So far this year, we’ve completed three strategic acquisitions and two tuck-in transactions that together are expected to add approximately $68 million in annualized revenue. Our most recent transactions include one in the highly in-demand cyber and information security space to expand our advisory services, and another that bolsters our retirement and investment solutions service offerings, and our overall M&A pipeline continues to remain active.”
2023 Outlook
•The Company increased its revenue growth expectations to within a range of 10% to 12% over the prior year, up from previous guidance of within a range of 8% to 10%.
•The Company expects an effective tax rate of approximately 28%. The increased rate, up from 25.5% in 2022, will impact diluted earnings per share by approximately $0.08.
•The Company expects a weighted average fully diluted share count of approximately 50.5 to 51.0 million shares.
Page 2 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz




•The Company expects GAAP fully diluted earnings per share to grow within a range of 15% to 17%, to $2.31 to $2.36 per share, over the $2.01 per share reported for 2022.
•The Company expects Adjusted fully diluted earnings per share to grow within a range of 11% to 13%, to $2.36 to $2.41 per share over the Adjusted earnings per share, of $2.13 per share reported for 2022.
Conference Call
CBIZ will host a conference call at 11:00 a.m. (ET) today to discuss its results. The call will be webcast and an archived replay will be available at https://cbiz.gcs-web.com/investor-overview. Participants may register at https://dpregister.com/sreg/10180368/f9d02de210.
About CBIZ
CBIZ is a leading provider of financial, insurance and advisory services to businesses throughout the United States. Financial services include accounting, tax, government health care consulting, transaction advisory, risk advisory, and valuation services. Insurance services include employee benefits consulting, retirement plan consulting, property and casualty insurance, payroll, and human capital consulting. With more than 120 offices in 33 states, CBIZ is one of the largest accounting and insurance brokerage providers in the U.S. For more information, visit www.cbiz.com.
Forward-Looking Statements
Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to, the risk that the anticipated benefits and perceived advantages of an acquisition may not be achieved; the impact of COVID-19 or governmental rules related to public health issues on the Company’s business, operations and clients; the Company’s ability to adequately manage and sustain its growth; the Company’s dependence on the trend of outsourcing business services; the Company’s dependence on the services of its CEO, other key employees, producers and service personnel; the effects of any potential cyber-attacks; competitive pricing pressures; general business and economic conditions; and changes in governmental laws or regulation affecting the Company’s clients, business, business services operations, or business models. A more detailed description of such risks and uncertainties may be found in the Company’s filings with the Securities and Exchange Commission at www.sec.gov.
Page 3 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz





CBIZ, INC.
FINANCIAL HIGHLIGHTS (UNAUDITED)
THREE MONTHS ENDED JUNE 30, 2023 AND 2022
(In thousands, except percentages and per share data)

  
Three Months Ended June 30,
2023 % 2022 %
Revenue $ 398,502  100.0  % $ 361,952  100.0  %
Operating expenses (1)
343,987  86.3  289,736  80.0 
Gross margin 54,515  13.7  72,216  20.0 
Corporate general and administrative expenses (1)
15,793  4.0  10,926  3.0 
Operating income 38,722  9.7  61,290  17.0 
Other income (expense):
Interest expense (5,534) (1.4) (1,645) (0.5)
Gain on sale of operations, net —  —  135  — 
Other income (expense), net (1) (2)
5,421  1.4  (15,903) (4.4)
Total other expense, net (113) —  (17,413) (4.9)
Income before income tax expense 38,609  9.7  43,877  12.1 
Income tax expense 11,746  12,622 
Net income $ 26,863  6.7  % $ 31,255  8.6  %
Diluted earnings per share $ 0.53  $ 0.60 
Diluted weighted average common shares outstanding 50,385  52,531 
Other data:
Adjusted EBITDA (3)
$ 54,435  $ 55,727 
Adjusted EPS (3)
$ 0.55  $ 0.63 

(1)CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and invested accordingly as directed by the employee. Income and expenses related to the deferred compensation plan are included in "Operating expenses" and "Corporate general and administrative expenses," and are directly offset by deferred compensation gains or losses in "Other income (expense), net." The deferred compensation plan has no impact on "Income before income tax expense."
Income and expenses related to the deferred compensation plan for the three months ended June 30, 2023, and 2022 are as follows (in thousands):
  
Three Months Ended June 30,
2023 % of Revenue 2022 % of Revenue
Operating expenses (income) $ 5,102  1.3  % $ (13,338) (3.7) %
Corporate general and administrative expenses (income) 631  0.1  % (1,811) (0.5) %
Other income (expense), net 5,733  1.4  % (15,149) (4.1) %

Page 4 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz




Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the three months ended June 30, 2023, and 2022 are as follows (in thousands):

  
Three Months Ended June 30,
2023 2022
As Reported Deferred Compensation Plan Adjusted % of Revenue As Reported Deferred Compensation Plan Adjusted % of Revenue
Gross margin $ 54,515  $ 5,102  $ 59,617  15.0  % $ 72,216  $ (13,338) $ 58,878  16.3  %
Operating income 38,722  5,733  44,455  11.2  % 61,290  (15,149) 46,141  12.7  %
Other income (expense), net 5,421  (5,733) (312) (0.1) % (15,903) 15,149  (754) (0.2) %
Income before income tax expense 38,609  —  38,609  9.7  % 43,877  —  43,877  12.1  %

(2)Included in "Other income (expense), net" for the three months ended June 30, 2023 and 2022, is expense of $0.8 million and $0.8 million, respectively, related to net changes in the fair value of contingent consideration related to CBIZ's prior acquisitions.

(3)Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the most directly comparable GAAP financial measure, and for additional information as to the usefulness of the Non-GAAP financial measures to shareholders and investors.

CBIZ, INC.
FINANCIAL HIGHLIGHTS (UNAUDITED)
SIX MONTHS ENDED JUNE 30, 2023 AND 2022
(In thousands, except percentages and per share data)

  
Six Months Ended June 30,
2023 % 2022 %
Revenue $ 853,108  100.0  % $ 753,674  100.0  %
Operating expenses (1)
684,998  80.3  580,035  77.0 
Gross margin 168,110  19.7  173,639  23.0 
Corporate general and administrative expenses (1)
31,391  3.7  27,235  3.6 
Operating income 136,719  16.0  146,404  19.4 
Other income (expense):
Interest expense (9,175) (1.1) (2,904) (0.4)
Gain on sale of operations, net 99  —  135  — 
Other income (expense), net (1) (2)
10,533  1.2  (22,310) (3.0)
Total other income (expense), net 1,457  0.1  (25,079) (3.4)
Income before income tax expense 138,176  16.1  121,325  16.0 
Income tax expense 38,153  31,943 
Net Income 100,023  11.7  89,382  11.9 
Diluted earnings per share $ 1.98  $ 1.70 
Diluted weighted average common shares outstanding 50,639  52,736 
Other data:
Adjusted EBITDA (3)
$ 167,783  $ 148,620 
Adjusted EPS (3)
$ 2.01  $ 1.81 

(1)CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and invested accordingly as directed by the employee. Income and expenses related to the deferred compensation plan are included in "Operating expenses" and "Corporate general and administrative expenses," and are directly offset by deferred compensation gains or losses in "Other income (expense), net." The deferred compensation plan has no impact on "Income before income tax expense."

Page 5 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz




Income and expenses related to the deferred compensation plan for the six months ended June 30, 2023, and 2022 are as follows (in thousands):
  
Six Months Ended June 30,
2023 % of Revenue 2022 % of Revenue
Operating expenses (income) $ 9,862  1.2  % $ (19,005) (2.5) %
Corporate general and administrative expenses (income) 1,273  0.1  % (2,622) (0.3) %
Other income (expense), net 11,135  1.3  % (21,627) (2.9) %
Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the six months ended June 30, 2023, and 2022 are as follows (in thousands):
  
Six Months Ended June 30,
2023 2022
As Reported Deferred Compensation Plan Adjusted % of Revenue As Reported Deferred Compensation Plan Adjusted % of Revenue
Gross margin $ 168,110  $ 9,862  $ 177,972  20.9  % $ 173,639  $ (19,005) $ 154,634  20.5  %
Operating income 136,719  11,135  147,854  17.3  % 146,404  (21,627) 124,777  16.6  %
Other income (expense), net 10,533  (11,135) (602) (0.1) % (22,310) 21,627  (683) (0.1) %
Income before income tax expense 138,176  —  138,176  16.1  % 121,325  —  121,325  16.0  %

(2)Included in "Other income (expense), net" for the six months ended June 30, 2023 and 2022, is expense of $1.4 million and $1.5 million, respectively, related to net changes in the fair value of contingent consideration related to CBIZ's prior acquisitions.

(3)Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the most directly comparable GAAP financial measure, and for additional information as to the usefulness of the Non-GAAP financial measures to shareholders and investors.

CBIZ, INC.
FINANCIAL HIGHLIGHTS (UNAUDITED)
(In thousands)
SELECT SEGMENT DATA

Three Months Ended June 30, Six Months Ended June 30,
2023 2022 2023 2022
Revenue
Financial Services $ 290,930  $ 259,308  $ 634,016  $ 548,054 
Benefits and Insurance Services 95,838  91,708  195,892  184,194 
National Practices 11,734  10,936  23,200  21,426 
Total $ 398,502  $ 361,952  $ 853,108  $ 753,674 
Gross Margin
Financial Services $ 47,485  $ 49,665  $ 146,128  $ 128,611 
Benefits and Insurance Services 17,464  16,688  40,595  36,517 
National Practices 1,189  1,037  2,072  1,951 
Operating expenses - unallocated (1):
Other expense (6,521) (8,512) (10,823) (12,445)
Deferred compensation (5,102) 13,338  (9,862) 19,005 
Total $ 54,515  $ 72,216  $ 168,110  $ 173,639 

Page 6 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz




(1)Represents operating expenses not directly allocated to individual businesses, including stock-based compensation, consolidation and integration charges, and certain advertising expenses. "Operating expenses - unallocated" also includes gains or losses attributable to the assets held in a rabbi trust associated with the Company's deferred compensation plan. These gains or losses do not impact "Income before income tax expense" as they are directly offset by the same adjustment to "Other income (expense), net" in the Consolidated Statements of Comprehensive Income. Net gains/losses recognized from adjustments to the fair value of the assets held in the rabbi trust are recorded as compensation expense (income) in "Operating expenses" and “Corporate, general and administrative expenses,” and offset in "Other income (expense), net."

CBIZ, INC.
SELECT CASH FLOW DATA (UNAUDITED)
(In thousands)

Six Months Ended June 30,
2023 2022
Net income $ 100,023  $ 89,382 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense 17,831  16,465 
Gain on sale of operations, net (99) (135)
Bad debt expense, net of recoveries 805  1,263 
Adjustments to contingent earnout liability, net 1,445  1,478 
Stock-based compensation expense 6,619  6,428 
Other noncash adjustments 4,671  4,890 
Net income, after adjustments to reconcile net income to net cash provided by operating activities 131,295  119,771 
Changes in assets and liabilities, net of acquisitions and divestitures (101,566) (91,263)
Net cash provided by operating activities 29,729  28,508 
Net cash used in investing activities (65,617) (89,756)
Net cash provided by financing activities 21,793  91,655 
Net (decrease) increase in cash, cash equivalents and restricted cash (14,095) 30,407 
Cash, cash equivalents and restricted cash at beginning of year $ 160,145  $ 150,474 
Cash, cash equivalents and restricted cash at end of period $ 146,050  $ 180,881 
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet:
Cash and cash equivalents $ 3,692  $ 3,881 
Restricted cash 52,314  42,188 
Cash equivalents included in funds held for clients 90,044  134,812 
Total cash, cash equivalents and restricted cash $ 146,050  $ 180,881 


Page 7 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz




CBIZ, INC.
SELECT FINANCIAL DATA AND RATIOS (UNAUDITED)
(In thousands)

June 30, 2023 December 31, 2022
Cash and cash equivalents 3,692  4,697 
Restricted cash 52,314  28,487 
Accounts receivable, net 456,397  334,498 
Current assets before funds held for clients 554,814  397,113 
Funds held for clients 131,374  171,313 
Goodwill and other intangible assets, net 1,014,673  951,702 
Total assets 2,088,755  1,879,124 
Current liabilities before client fund obligations 367,908  338,940 
Client fund obligations 133,069  173,467 
Total long-term debt, net 408,790  263,654 
Total liabilities 1,312,712  1,165,672 
Treasury stock (882,088) (824,778)
Total stockholders' equity 776,043  713,452 
Debt to equity 52.7  % 37.0  %
Days sales outstanding (DSO) (1)
89  74 
Shares outstanding 49,822  50,180 
Basic weighted average common shares outstanding 50,164  51,502 
Diluted weighted average common shares outstanding 50,639  52,388 

(1)DSO is provided for continuing operations and represents accounts receivable, net, at the end of the period, divided by trailing twelve month daily revenue. The Company has included DSO data because such data is commonly used as a performance measure by analysts and investors and as a measure of the Company's ability to collect on receivables in a timely manner. DSO should not be regarded as an alternative or replacement to any measurement of performance under GAAP. DSO on June 30, 2022 was 88.


















Page 8 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz




CBIZ, INC.
GAAP RECONCILIATION
Net Income and Diluted Earnings Per Share (“EPS”) to Adjusted Net Income, EPS and EBITDA(1)
(In thousands, except per share data)

Three Months Ended June 30, 2023 Three Months Ended June 30, 2022
Amounts EPS Amounts EPS
Net income $ 26,863  $ 0.53  $ 31,255  $ 0.60 
Adjustments:
Integration & retention costs related to acquisitions (2)
865  0.03  2,048  0.04 
Facility optimization costs (3)
221  —  —  — 
Income tax effect related to adjustments (330) (0.01) (589) (0.01)
Adjusted net income $ 27,619  $ 0.55  $ 32,714  $ 0.63 
Interest expense $ 5,534  $ 1,645 
Income tax expense 11,746  12,622 
Gain on sale of operations, net —  (135)
Tax effect related to the adjustments above 330  589 
Depreciation 3,116  2,828 
Amortization 6,090  5,464 
Adjusted EBITDA $ 54,435  $ 55,727 
Six Months Ended June 30, 2023 Six Months Ended June 30, 2022
Amounts EPS Amounts EPS
Net income $ 100,023  $ 1.98  $ 89,382  $ 1.70 
Adjustments:
Transaction costs related to acquisitions (2)
611  0.01  1,329  0.03 
Integration & retention costs related to acquisitions (2)
1,868  0.04  6,732  0.13 
Facility optimization costs (3)
221  —  —  — 
Income tax effect related to adjustments (746) (0.02) (2,122) (0.05)
Adjusted net income $ 101,977  $ 2.01  $ 95,321  $ 1.81 
Interest expense $ 9,175  $ 2,904 
Income tax expense 38,153  31,943 
Gain on sale of operations, net (99) (135)
Tax effect related to the adjustments above 746  2,122 
Depreciation 6,091  5,607 
Amortization 11,740  10,858 
Adjusted EBITDA $ 167,783  $ 148,620 

(1)CBIZ reports its financial results in accordance with GAAP. This table reconciles Adjusted net income, Adjusted EPS and Adjusted EBITDA to the most directly comparable GAAP financial measures, “Net income” and "Diluted earnings per share." Adjusted net income, Adjusted EPS and Adjusted EBITDA are not defined by GAAP and should not be regarded as an alternative or replacement to any measurement of performance under GAAP. Adjusted net income, Adjusted EPS and Adjusted EBITDA, which excludes significant non-operating related gains and losses, are used by the Company for its shareholders and debt holders as a performance measure to evaluate, assess and benchmark the Company's operational results.

(2)These costs include, but are not limited to, certain consulting, technology, personnel, as well as other first year operating and general administrative costs that are non-recurring in nature. Amounts reported in 2023 related to the costs incurred related to the Somerset acquisition and those reported in 2022 related to the Marks Paneth acquisition.

(3) These costs related to incremental non-recurring lease expense incurred as a result of CBIZ's real estate optimization efforts.


Page 9 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz




CBIZ, INC.
GAAP RECONCILIATION
Full Year 2023 Net Income and Diluted Earnings Per Share (“EPS”) to
Adjusted Net Income, EPS and EBITDA Guidance
(Amount in millions, except per share data)
Full Year 2023 Guidance
Low High
Amount Per Share Amount Per Share
Net income $ 121.1  $ 2.31  $ 123.2  $ 2.36 
Transaction and integration costs related to Somerset (1)
3.6  0.07  3.6  0.07 
Income tax effect related to adjustments (1.0) $ (0.02) (1.0) $ (0.02)
Adjusted net income $ 123.7  $ 2.36  $ 125.8  $ 2.41 
Interest expense $ 20.8  $ 20.8 
Income tax expense 47.2  47.2 
Tax effect related to the adjustments above 1.0  1.0 
Depreciation and amortization 35.9  35.9 
Adjusted EBITDA $ 228.6  $ 230.7 
GAAP diluted EPS for 2022 $ 2.01  $ 2.01 
Adjusted diluted EPS for 2022 (2)
$ 2.13  $ 2.13 
GAAP diluted EPS range 15  % 17  %
 Adjusted diluted EPS range 11  % 13  %
GAAP Net income for 2022 $ 105.4  $ 105.4 
GAAP Net income range 15  % 17  %

(1)Includes estimated integration costs related to the Somerset acquisition. Such costs include, but are not limited to, certain consulting, technology, personnel, as well as other first year operating and general administrative costs that are non-recurring in nature.
(2)A reconciliation between net income and adjusted net income and a reconciliation between GAAP diluted EPS and Adjusted diluted EPS for fiscal year ended December 31, 2022 are presented as follows:
  
Year Ended December 31, 2022
In millions EPS
Net income $ 105.4  $ 2.01 
Adjustments:
Gain on sale of assets, net (2.4) (0.05)
Transaction costs related to Marks Paneth 1.3  0.03 
Integration and retention costs related to Marks Paneth 9.2  0.18 
Income tax effect related to adjustments (2.1) (0.04)
Adjusted net income $ 111.4  $ 2.13 
Page 10 of 10

NYSE: CBZ ● www.cbiz.com ● Twitter @cbz